Viral Vectors for Gene Therapy
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 80 (1) , 35-47
- https://doi.org/10.1016/s0163-7258(98)00020-5
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- A two-component expression system that responds to inflammatory stimuli in vivoNature Biotechnology, 1997
- A Phase I Study of Vaccination with Autologous, Irradiated Melanoma Cells Engineered to Secrete Human Granulocyte-Macrophage Colony Stimulating Factor. Dana-Farber Cancer Institute, Boston, MassachusettsHuman Gene Therapy, 1997
- Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical TrialsAnnals of the New York Academy of Sciences, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Gene therapy strategies for novel cancer therapeuticsCurrent Opinion in Oncology, 1996
- Development of Cell Lines Capable of Complementing E1, E4, and Protein IX Defective Adenovirus Type 5 MutantsHuman Gene Therapy, 1995
- AAV as a viral vector for human gene therapyMolecular Biotechnology, 1995
- Retroviral Vectors for Use in Human Gene Therapy for Cancer, Gaucher Disease, and ArthritisaAnnals of the New York Academy of Sciences, 1994
- Gene Therapy of Cystic Fibrosis Lung Disease Using E1 Deleted Adenoviruses: A Phase I Trial. University of Michigan, Ann Arbor, Michigan and University of Pennsylvania, Philadelphia, PennsylvaniaHuman Gene Therapy, 1994
- Adeno-associated virus: integration at a specific chromosomal locusCurrent Opinion in Genetics & Development, 1993